X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (12) 12
rheumatology (11) 11
treatment outcome (8) 8
double-blind method (7) 7
drug therapy, combination (7) 7
golimumab (7) 7
male (7) 7
safety (7) 7
antirheumatic agents - therapeutic use (6) 6
rheumatoid arthritis (6) 6
adult (5) 5
antibodies, monoclonal - administration & dosage (5) 5
antibodies, monoclonal - therapeutic use (5) 5
antirheumatic agents - administration & dosage (5) 5
arthritis, rheumatoid - drug therapy (5) 5
clinical trials (5) 5
female (5) 5
methotrexate - therapeutic use (5) 5
middle aged (5) 5
patients (5) 5
pharmacokinetics (5) 5
phase-iii (5) 5
recommendations (5) 5
antibodies, monoclonal - adverse effects (4) 4
antirheumatic agents - adverse effects (4) 4
arthritis (4) 4
arthritis, psoriatic - drug therapy (4) 4
biologics (4) 4
efficacy (4) 4
life sciences (4) 4
methotrexate (4) 4
necrosis-factor-alpha (4) 4
psoriatic arthritis (4) 4
1506 (3) 3
abridged index medicus (3) 3
animals (3) 3
ankylosing spondylitis (3) 3
autolysosome (3) 3
autophagosome (3) 3
chaperone-mediated autophagy (3) 3
clinical and epidemiological research (3) 3
etanercept (3) 3
flux (3) 3
immunogenicity (3) 3
improvement (3) 3
injections, subcutaneous (3) 3
lc3 (3) 3
lysosome (3) 3
macroautophagy (3) 3
methotrexate - administration & dosage (3) 3
methotrexate therapy (3) 3
phagophore (3) 3
radiography (3) 3
rheumatoid-arthritis (3) 3
stress (3) 3
studies (3) 3
tumor necrosis factor-tnf (3) 3
vacuole (3) 3
adolescent (2) 2
aged (2) 2
american-college (2) 2
ankylosing-spondylitis (2) 2
antibodies, monoclonal - pharmacokinetics (2) 2
antibody (2) 2
antidrug antibodies (2) 2
antirheumatic agents - pharmacokinetics (2) 2
arthritis, psoriatic - immunology (2) 2
arthritis, rheumatoid - diagnostic imaging (2) 2
association (2) 2
care and treatment (2) 2
cell biology (2) 2
cellular biology (2) 2
computer simulation (2) 2
criteria (2) 2
data bases (2) 2
disease-activity (2) 2
disease-activity index (2) 2
double-blind (2) 2
drug administration schedule (2) 2
every 4 weeks (2) 2
follow-up studies (2) 2
impact (2) 2
infliximab (2) 2
intravenous (2) 2
long-term safety (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
methotrexate - adverse effects (2) 2
methotrexate - pharmacokinetics (2) 2
multicenter (2) 2
pharmacology & pharmacy (2) 2
preliminary definition (2) 2
progression (2) 2
psoriasis (2) 2
reported outcomes (2) 2
therapy (2) 2
usage (2) 2
validation (2) 2
0601 biochemistry and cell biology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Klionsky, Daniel J and Abdelmohsen, Kotb and Abe, Akihisa and Abedin, Md Joynal and Abeliovich, Hagai and Arozena, Abraham Acevedo and Adachi, Hiroaki and Adams, Christopher M and Adams, Peter D and Adeli, Khosrow and Adhihetty, Peter J and Adler, Sharon G and Agam, Galila and Agarwal, Rajesh and Aghi, Manish K and Agnello, Maria and Agostinis, Patrizia and Aguilar, Patricia V and Aguirre-Ghiso, Julio and Airoldi, Edoardo M and Ait-Si-Ali, Slimane and Akematsu, Takahiko and Akporiaye, Emmanuel T and Al-Rubeai, Mohamed and Albaiceta, Guillermo M and Albanese, Chris and Albani, Diego and Albert, Matthew L and Aldudo, Jesus and Alguel, Hana and Alirezaei, Mehrdad and Alloza, Iraide and Almasan, Alexanu and Almonte-Beceril, Maylin and Alnemri, Emad S and Alonso, Covadonga and Altan-Bonnet, Nihal and Altieri, Dario C and Alvarez, Silvia and Alvarez-Erviti, Lydia and Alves, Sano and Amadoro, Giuseppina and Amano, Atsuo and Amantini, Consuelo and Ambrosio, Santiago and Amelio, Ivano and Amer, Amal O and Amessou, Mohamed and Amon, Angelika and An, Zhenyi and Anania, Frank A and Andersen, Stig U and Andley, Usha P and Aneadi, Catherine K and Anieu-Abadie, Nathalie and Anel, Alberto and Ann, David K and Anoopkumar-Dukie, Shailena and Antonioli, Manuela and Aoki, Hiroshi and Apostolova, Nadezda and Aquila, Saveria and Aquilano, Katia and Araki, Koichi and Arama, Eli and Aranda, Agustin and Araya, Jun and Arcaro, Alexane and Arias, Esperanza and Arimoto, Hirokazu and Ariosa, Aileen R and Armstrong, Jane L and Arnould, Thierry and Arsov, Ivica and Asanuma, Katsuhiko and Askanas, Valerie and Asselin, Eric and Atarashi, Ryuichiro and Atherton, Sally S and Atkin, Julie D and Attardi, Laura D and Auberger, Patrick and Auburger, Georg and Aurelian, Laure and Autelli, Riccardo and Avagliano, Laura and Avantaggiati, Maria Laura and Avrahami, Limor and Awale, Suresh and Azad, Neelam and Bachetti, Tiziana and Backer, Jonathan M and Bae, Dong-Hun and Bae, Jae-Sung and Bae, Ok-Nam and Bae, Soo Han and Baehrecke, Eric H and Baek, Seung-Hoon and Baghdiguian, Stephen and Bagniewska-Zadworna, Agnieszka and ...
Autophagy, ISSN 1554-8627, 2016, Volume 12, Issue 1, pp. 1 - 222
Journal Article
by Klionsky, Daniel J and Abdelmohsen, Kotb and Abe, Akihisa and Abedin, Md Joynal and Abeliovich, Hagai and Arozena, Abraham Acevedo and Adachi, Hiroaki and Adams, Christopher M and Adams, Peter D and Adeli, Khosrow and Adhihetty, Peter J and Adler, Sharon G and Agam, Galila and Agarwal, Rajesh and Aghi, Manish K and Agnello, Maria and Agostinis, Patrizia and Aguilar, Patricia V and Aguirre-Ghiso, Julio A and Airoldi, Edoardo M and Ait-Si-Ali, Slimane and Akematsu, Takahiko and Akporiaye, Emmanuel T and Al-Rubeai, Mohamed and Albaiceta, Guillermo M and Albanese, Chris and Albani, Diego and Albert, Matthew L and Aldudo, Jesus and Alguel, Hana and Alirezaei, Mehrdad and Alloza, Iraide and Almasan, Alexanu and Almonte-Beceril, Maylin and Alnemri, Emad S and Alonso, Covadonga and Altan-Bonnet, Nihal and Altieri, Dario C and Alvarez, Silvia and Alvarez-Erviti, Lydia and Alves, Sano and Amadoro, Giuseppina and Amano, Atsuo and Amantini, Consuelo and Ambrosio, Santiago and Amelio, Ivano and Amer, Amal O and Amessou, Mohamed and Amon, Angelika and Liu, Zhenyi and Anania, Frank A and Andersen, Stig U and Andley, Usha P and Aneadi, Catherine K and Anieu-Abadie, Nathalie and Anel, Alberto and Ann, David K and Anoopkumar-Dukie, Shailena and Antonioli, Manuela and Aoki, Hiroshi and Apostolova, Nadezda and Aquila, Saveria and Aquilano, Katia and Araki, Koichi and Arama, Eli and Aranda, Agustin and Araya, Jun and Arcaro, Alexane and Arias, Esperanza and Arimoto, Hirokazu and Ariosa, Aileen R and Armstrong, Jane L and Arnould, Thierry and Arsov, Ivica and Asanuma, Katsuhiko and Askanas, Valerie and Asselin, Eric and Atarashi, Ryuichiro and Atherton, Sally S and Atkin, Julie D and Attardi, Laura D and Auberger, Patrick and Auburger, Georg and Aurelian, Laure and Autelli, Riccardo and Avagliano, Laura and Avantaggiati, Maria Laura and Avrahami, Limor and Awale, Suresh and Azad, Neelam and Bachetti, Tiziana and Backer, Jonathan M and Bae, Dong-Hun and Bae, Jae-Sung and Bae, Ok-Nam and Bae, Soo Han and Baehrecke, Eric H and Baek, Seung-Hoon and Baghdiguian, Stephen and Bagniewska-Zadworna, Agnieszka and ... and Medicinska fakulteten and Institutionen för medicinsk kemi och biofysik and Umeå universitet
Autophagy, ISSN 1554-8627, 2016, Volume 12, Issue 1, pp. 1 - 222
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2018, Volume 77, Issue 1, pp. 21 - 29
Journal Article
by Deodhar, Atul and Gensler, Lianne S and Sieper, Joachim and Clark, Michael and Calderon, Cesar and Wang, Yuhua and Zhou, Yiying and Leu, Jocelyn H and Campbell, Kim and Sweet, Kristen and Harrison, Diane D and Hsia, Elizabeth C and Heijde, Désirée and Ariel, Frederico and Asnal, Cecilia Adma and Berman, Alberto and Citera, Gustavo and Rodriguez, Graciela and Savio, Veronica Gabriela and Bird, Paul and Griffiths, Hedley and Nicholls, David and Rischmueller, Maureen and Zochling, Jane and De Vlam, Kurt and Malaise, Michel and Toukap, Adrien Nzeusseu and Van den Bosch, Filip and Vanhoof, Johan and Bonfiglioli, Rubens and Keiserman, Mauro and Scotton, Antonio Scafuto and Xavier, Ricardo and Ximenes, Antonio Carlos and Atanasov, Assen and Goranov, Ivan and Kazmin, Ivan and Licheva, Rodina Nestorova and Nikolov, Nikolay and Oparanov, Boycho and Stoilov, Rumen and Bessette, Louis and Rodrigues, Jude and Bortilik, Ladislav and Dokoupilova, Eva and Dvoarak, Zdenek and Galatikova, Dagmar and Nemec, Petr and Podrazilova, Lucie and Simkova, Gabriela and Stejfova, Zuzana and Moravcova, Radka and Vitek, Petr and Cantagrel, Alain and Baillet, Athan and Banneville, Beatrice and Combe, Bernard and Breban, Maxime and Nguyen, Minh and Goupille, Philippe and Braun, Juergen and Everding, Andrea and Kekow, Joern and Koenig, Ramona and Rubbert‐Roth, Andrea and Witte, Torsten and Bartha, Attila and Drescher, Edit and Kerekes, Kata and Kovacs, Attila and Pulai, Judit and Rojkovich, Bernadette and Szanto, Sandor and Toth, Edit and Avila, Hilario and Torre, Igancio Garcia and Irazoque, Fedra and Maradiaga, Marco and Pacheco, Cesar and Brzosko, Marek and Dudek, Anna and Jeka, Slawomir and Krogulec, Marek and Kwiatkowska, Brygida and Wiland, Piotr and Wojciechowski, Rafal and Zielinska, Agnieszka and Santos, Helena and Bugrova, Olga and Christyakov, Valery and Gorbunov, Vladimir and Ilivanova, Elena and Zemerova, Elena and Kamalova, Rima and Kameneva, Tatyana and Macievskaya, Galina and Marusenko, Irina and Maslyansky, Alexey and Myasoedova, Svetlana and Myasoutova, Leisan and ...
Arthritis & Rheumatology, ISSN 2326-5191, 02/2019, Volume 71, Issue 2, pp. 258 - 270
Objective To evaluate the efficacy and safety of ustekinumab in 3 randomized, placebo‐controlled studies in patients with axial spondyloarthritis (SpA).... 
PATHOGENESIS | CRITERIA | CELLS | MAINTENANCE | THERAPY | ANKYLOSING-SPONDYLITIS | PHASE-3 | RHEUMATOLOGY | ASSOCIATION | ACTIVE PSORIATIC-ARTHRITIS | INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY | Effectiveness | Safety measures | Rheumatic diseases | Clinical trials | Arthritis | Patients | Inflammatory diseases | Studies | Intolerance | Randomization | Tumor necrosis factor | Tumor necrosis factor-TNF | Safety
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 11/2017, Volume 69, Issue 11, pp. 2151 - 2161
Objective To evaluate the safety and efficacy of intravenous (IV) golimumab treatment in psoriatic arthritis (PsA). Methods In this phase III, randomized,... 
Self-propagating synthesis | Signs and symptoms | Intravenous administration | Psoriasis | Arthritis | Safety | Patients | Anticancer properties
Journal Article
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 03/2014, Volume 66, pp. S55 - S56
Background/Purpose: To assess the pharmacokinetics (PK) and PK‐efficacy correlations of body surface area (BSA)‐adjusted dosing of 30 mg/m2 golimumab... 
Journal Article
Journal Article
JOURNAL OF RHEUMATOLOGY, ISSN 0315-162X, 10/2019, Volume 46, Issue 10, pp. 1277 - 1283
Objective. Evaluate safety and efficacy of intravenous (IV) golimumab (GOL) in patients with active ankylosing spondylitis (AS) through 1 year. Methods. A... 
RECOMMENDATIONS | GOLIMUMAB | PREFERENCES | ANTI-TUMOR NECROSIS FACTOR THERAPY | IMPROVEMENT | ANKYLOSING SPONDYLITIS | RHEUMATOLOGY | BIOLOGICS | BATH | INTRAVENOUS
Journal Article
Journal Article
Arthritis care & research, ISSN 2151-464X, 04/2019
Evaluate safety and efficacy of intravenous golimumab in patients with active psoriatic arthritis (PsA) through 1 year. GO-VIBRANT was a Phase 3, randomized,... 
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 03/2018, Volume 45, Issue 3, pp. 341 - 348
Objective. To evaluate the safety and efficacy of intravenous golimumab (GOL) in patients with active ankylosing spondylitis (AS). Methods. In a phase III,... 
Golimumab | Antitumor necrosis factor | Intravenous | Ankylosing spondylitis | GOLIMUMAB | ACTIVE RHEUMATOID-ARTHRITIS | PHASE-III | NECROSIS-FACTOR-ALPHA | ANKYLOSING SPONDYLITIS | PATIENT PREFERENCES | RHEUMATOLOGY | EVERY 4 WEEKS | PSORIATIC-ARTHRITIS | METROLOGY INDEX | ANTITUMOR NECROSIS FACTOR | METHOTREXATE THERAPY | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | INTRAVENOUS
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 10/2018, Volume 34, Issue S1, pp. 1 - 407
Journal Article
INFLAMMATORY BOWEL DISEASES, ISSN 1078-0998, 09/2019, Volume 25, Issue 9, pp. 1532 - 1540
Background: Antidrug antibody (ADA) detection with standard bridging enzyme immunoassays (EIA) can yield false-negative results or underestimate titers through... 
DRUG | CROHNS-DISEASE | EFFICACY | golimumab | antidrug antibodies | bridging enzyme immunoassay | INDUCTION THERAPY | PHARMACOKINETICS | RECOMMENDATIONS | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | HOST ANTIBODIES
Journal Article